Cephalon To Pay $425M To End Federal Investigation

Law360, New York (November 9, 2007, 12:00 AM EST) -- Drugmaker Cephalon Inc. has agreed to pay $425 million to settle an investigation into the company's sales and marketing practices by the Philadelphia U.S. Attorney's office and the U.S. Department of Justice, the company revealed Thursday.

As part of the settlement, Cephalon said it would also accept a single misdemeanor violation of the U.S. Food, Drug and Cosmetic Act. The deal puts to rest federal and related state Medicaid claims, according to Cephalon. The Frazer, Penn.- based pharmaceutical company also said it intends to sign a...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.